Genetic editing of CISH enhances T cell effector programs independently of immune checkpoint cell surface ligand expression
E. Arthofer, K. Chakraborty, L. Viney, M. J. Johnson, B. R. Webber, B. S. Moriarity, E. Lou, M. Choudhry, C. A. Klebanoff, T. Henley
This study shows that genetic editing of CISH enhances T cell anti-tumor activity independently of PD-L1 expression, outperforming PD-1 and TIGIT disruption in certain contexts.
bioRxiv · Aug 17, 2021 · PreprintCancer Biology